Pharmacoeconomics of Neoral, a new formulation of cyclosporine, in renal transplantation.
Abella
I
I
Department of Health Economics, Sandoz Pharma Ltd, Basel, Switzerland.
D000284:Administration, Oral; D002986:Clinical Trials as Topic; D003365:Costs and Cost Analysis; D016572:Cyclosporine / Q000008:administration & dosage / Q000191:economics* / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006760:Hospitalization / Q000191:economics; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000191:economics* / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000191:economics* / Q000276:immunology*
D007166:Immunosuppressive Agents; D016572:Cyclosporine